About Select Medical Holdings Corporation
https://www.selectmedical.comSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.
CEO
Thomas P. Mullin
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-11-26 | Forward | 232:125 |
ETFs Holding This Stock
Summary
Showing Top 3 of 195
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:19.15M
Value:$288.72M
BLACKROCK INC.
Shares:16.88M
Value:$254.54M
PRICE T ROWE ASSOCIATES INC /MD/
Shares:15.92M
Value:$240.1M
Summary
Showing Top 3 of 359
About Select Medical Holdings Corporation
https://www.selectmedical.comSelect Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.36B ▲ | $74.49M ▲ | $28.79M ▼ | 2.11% ▼ | $0.23 ▼ | $120.29M ▼ |
| Q2-2025 | $1.34B ▼ | $68.92M ▲ | $40.57M ▼ | 3.03% ▼ | $0.32 ▼ | $135M ▼ |
| Q1-2025 | $1.35B ▲ | $67.82M ▲ | $56.68M ▲ | 4.19% ▼ | $0.44 ▲ | $160.06M ▲ |
| Q4-2024 | $-122.59M ▼ | $65.09M ▼ | $-16.05M ▼ | 13.09% ▲ | $-0.12 ▼ | $-182.65M ▼ |
| Q3-2024 | $1.76B | $96.19M | $55.63M | 3.16% | $0.43 | $213.41M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $60.05M ▲ | $5.69B ▼ | $3.67B ▼ | $1.69B ▲ |
| Q2-2025 | $52.35M ▼ | $5.74B ▲ | $3.74B ▲ | $1.67B ▼ |
| Q1-2025 | $53.21M ▼ | $5.7B ▲ | $3.65B ▲ | $1.72B ▲ |
| Q4-2024 | $59.69M ▼ | $5.61B ▼ | $3.61B ▼ | $1.68B ▼ |
| Q3-2024 | $191.47M | $8B | $5.7B | $1.92B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $44.18M ▼ | $175.31M ▲ | $-32.61M ▲ | $-134.99M ▼ | $7.71M ▲ | $122.2M ▲ |
| Q2-2025 | $57.88M ▼ | $110.29M ▲ | $-64.67M ▼ | $-46.49M ▼ | $-864K ▲ | $45.61M ▲ |
| Q1-2025 | $74.73M ▲ | $-3.46M ▼ | $-52.31M ▲ | $49.29M ▲ | $-6.48M ▲ | $-55.8M ▼ |
| Q4-2024 | $3.76M ▼ | $125.43M ▼ | $-74.19M ▼ | $-183.01M ▼ | $-131.77M ▼ | $62M ▼ |
| Q3-2024 | $81.02M | $180.97M | $-45.09M | $-55.57M | $80.31M | $130.29M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Health Care Patient Service Medicare | $370.00M ▲ | $390.00M ▲ | $380.00M ▼ | $390.00M ▲ |
 Health Care Patient Service NonMedicare | $-620.00M ▲ | $830.00M ▲ | $830.00M ▲ | $840.00M ▲ |
 Service Other | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ | $130.00M ▲ |
CEO
Thomas P. Mullin
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2024-11-26 | Forward | 232:125 |
ETFs Holding This Stock
Summary
Showing Top 3 of 195
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:19.15M
Value:$288.72M
BLACKROCK INC.
Shares:16.88M
Value:$254.54M
PRICE T ROWE ASSOCIATES INC /MD/
Shares:15.92M
Value:$240.1M
Summary
Showing Top 3 of 359